Education
About Us
Working with TipRanks
Follow Us
Pharming Group (PHAR)
NASDAQ:PHAR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 297.20M | $ 245.32M | $ 205.62M | $ 198.87M | $ 212.17M |
| Gross Profit | $ 261.80M | $ 220.10M | $ 188.06M | $ 177.73M | $ 188.63M |
| Operating Income | $ -8.62M | $ -5.39M | $ 18.23M | $ 13.56M | $ 76.26M |
| EBITDA | $ 16.32M | $ 9.88M | $ 33.53M | $ 48.78M | $ 58.35M |
| Net Income | $ -11.84M | $ -10.55M | $ 13.67M | $ 16.00M | $ 37.75M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 167.89M | $ 213.42M | $ 207.34M | $ 191.92M | $ 167.94M |
| Total Assets | $ 399.99M | $ 462.85M | $ 425.80M | $ 397.31M | $ 342.55M |
| Total Debt | $ 112.31M | $ 171.54M | $ 166.69M | $ 161.76M | $ 132.58M |
| Net Debt | $ 57.37M | $ 109.80M | $ -40.65M | $ -30.16M | $ -35.36M |
| Total Liabilities | $ 178.92M | $ 244.07M | $ 221.16M | $ 204.40M | $ 192.39M |
| Stockholders' Equity | $ 221.06M | $ 218.78M | $ 204.64M | $ 192.92M | $ 150.16M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.59M | $ -18.77M | $ 20.48M | $ 21.13M | $ 68.33M |
| Operating Cash Flow | $ -1.79M | $ -17.30M | $ 22.46M | $ 37.84M | $ 83.63M |
| Investing Cash Flow | $ 31.62M | $ -129.39M | $ 5.32M | $ -21.30M | $ -15.63M |
| Financing Cash Flow | $ -34.41M | $ -1.04M | $ -4.98M | $ -27.95M | $ 60.69M |